Cargando…

The practice of medicinal chemistry /

The Practice of Medicinal Chemistry, Fourth Edition, provides a practical and comprehensive overview of the daily issues facing pharmaceutical researchers and chemists. In addition to its thorough and excellent treatment of basic medicinal chemistry principles, this updated edition has been thorough...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Wermuth, C. G. (Editor ), Aldous, David (David John) (Editor ), Raboisson, Pierre (Editor ), Rognan, Didier (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London, UK : Academic Press, 2015.
Edición:Fourth edition.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 KNOVEL_ocn913530203
003 OCoLC
005 20231027140348.0
006 m o d
007 cr cnu---unuuu
008 150709s2015 enk ob 001 0 eng d
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d KNOVL  |d OCLCF  |d EBLCP  |d YDXCP  |d ZCU  |d DEBSZ  |d DXU  |d YDX  |d VGM  |d OCLCQ  |d S4S  |d COO  |d U3W  |d D6H  |d RRP  |d N$T  |d MERER  |d WYU  |d OCLCQ  |d DCT  |d OCLCQ  |d OCLCO  |d OCLCQ 
019 |a 913694294  |a 920816765  |a 959423590 
020 |a 9780124172135  |q (electronic bk.) 
020 |a 012417213X  |q (electronic bk.) 
020 |z 9780124172050 
020 |z 0124172059 
029 1 |a AU@  |b 000058366661 
029 1 |a AU@  |b 000059395865 
029 1 |a CHBIS  |b 010548016 
029 1 |a CHVBK  |b 341779504 
029 1 |a DEBSZ  |b 45152747X 
029 1 |a GBVCP  |b 856591483 
035 |a (OCoLC)913530203  |z (OCoLC)913694294  |z (OCoLC)920816765  |z (OCoLC)959423590 
050 4 |a RS403 
060 4 |a QV 744 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615.1/9  |2 23 
049 |a UAMI 
245 0 4 |a The practice of medicinal chemistry /  |c edited by Camille Georges Wermuth, David Aldous, Pierre Raboisson, Didier Rognan. 
250 |a Fourth edition. 
264 1 |a London, UK :  |b Academic Press,  |c 2015. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a The Practice of Medicinal Chemistry, Fourth Edition, provides a practical and comprehensive overview of the daily issues facing pharmaceutical researchers and chemists. In addition to its thorough and excellent treatment of basic medicinal chemistry principles, this updated edition has been thoroughly revised to provide new and expanded coverage of the latest technologies and approaches in drug discovery. With in-depth coverage of high content screening, scoring, docking, binding free energy calculations, polypharmacology, QSAR, chemical collections and databases, and much more, this book is the go-to reference for all academic and pharmaceutical researchers who need a complete understanding of medicinal chemistry and its application to drug discovery and development. 
500 |a Includes index. 
588 0 |a Online resource; title from PDF title page (ScienceDirect, viewed July 9, 2015). 
505 0 |a Front Cover; The Practice of Medicinal Chemistry; Copyright Page; Contents; List of Contributors; Foreword; Preface to the Fourth Edition; Preface to the Third Edition; Preface to the Second Edition; Preface to the First Edition; I. General Aspects of Medicinal Chemistry; 1 Medicinal Chemistry: Definitions and Objectives, Drug Activity Phases, Drug Classification Systems; I. Definitions and Objectives; A Medicinal Chemistry and Related Disciplines and Terms; B Drugs and Drug Substances; C Stages of Drug Development; II. Drug Activity Phases; A The Pharmaceutical Phase. 
505 8 |a B The Pharmacokinetic PhaseC The Pharmacodynamic Phase; D The Road to Successful Drug Development?; III. Drug Classification Systems; A Classification by Target and Mechanism of Action; 1 Targets; 2 Mechanisms of Action; B Other Classification Systems; References; 2 Evaluation of the Biological Activity of Compounds: Techniques and Mechanism of Action Studies; I. Introduction; II. Drug Discovery Approaches and Screening Cascades; A Target Based Screening; B Phenotypic Screening; III. In Vitro Assays; A Primary Assays; Glossary; 1 Binding assays; 2 Binding Studies: Principles and Analysis. 
505 8 |a 3 Enzyme Assays4 Types of Enzyme Inhibition and Their Analysis; A Reversible Inhibitors; B Irreversible Inhibitors; C Competitive Inhibitors; D Noncompetitive Inhibitors; E Uncompetitive Inhibitors; 5 Functional Assays; 6 Functional Studies and Their Analysis; A Agonist Concentration-Effect (E/[A]) Curves; B Full Agonists, Partial Agonists, and Inverse Agonists; C Optimizing Agonists; D Analysis of Antagonists; Competitive Antagonists; Irreversible, Noncompetitive, and Allosteric Antagonists; B Compound Interference in Primary Assays: Artifacts and False Positives; C Assay Biostatistics. 
505 8 |a D Selectivity, Cytotoxicity, and Species Cross-over. 1 Selectivity; 2 Cytotoxicity; 3 Species Crossover; E Cellular and Tissue Functional Responses; IV. Ex Vivo Assays; V. In Vivo Assays; A Pharmacokinetic Models; B Efficacy Models; C Safety Testing; Acknowledgements; References; 3 Drug Targets, Target Identification, Validation, and Screening; I. Introduction; II. What is a Drug Target?; III. The Purpose of Target Identification; A Target-Based Screening; B Phenotypic Screening; C Fast Follower Strategy; IV. Target Options and Treatment Options; V. Target Deconvolution and Target Discovery. 
505 8 |a VI. Methods for Target Identification and ValidationA Affinity Chromatography; B Genetic Methods; C Haploinsufficiency Profiling in Yeast; D Analysis of Resistant Mutants; E siRNA for Target Validation; F Yeast Three-Hybrid System; G DNA Microarrays; H Comparative Profiling; I Analysis of the Pathophysiology; J The Study of Existing Drugs; K Systems Biology; L In Silico Simulation of the Human Patient; VII. Target Validation; VIII. Conclusion; References; II. Lead Compound Discovery Strategies; 4 Strategies in the Search for New Lead Compounds or Original Working Hypotheses; I. Introduction. 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
590 |a Knovel  |b ACADEMIC - Pharmaceuticals, Cosmetics & Toiletries 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Drugs  |x Design. 
650 2 |a Chemistry, Pharmaceutical 
650 2 |a Drug Design 
650 6 |a Chimie pharmaceutique. 
650 6 |a Médicaments  |x Conception. 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Drugs  |x Design.  |2 fast  |0 (OCoLC)fst00898790 
650 7 |a Pharmaceutical chemistry.  |2 fast  |0 (OCoLC)fst01060115 
700 1 |a Wermuth, C. G.,  |e editor. 
700 1 |a Aldous, David  |q (David John),  |e editor. 
700 1 |a Raboisson, Pierre,  |e editor. 
700 1 |a Rognan, Didier,  |e editor. 
776 0 8 |i Print version:  |t Practice of medicinal chemistry.  |b Fourth edition.  |d London, UK : Academic Press, 2015  |z 9780124172050 
856 4 0 |u https://appknovel.uam.elogim.com/kn/resources/kpPMCE0015/toc  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL2079962 
938 |a EBSCOhost  |b EBSC  |n 596616 
938 |a YBP Library Services  |b YANK  |n 12514376 
994 |a 92  |b IZTAP